NCT02303236View on ClinicalTrials.gov

Biological Markers Predicting Exercise Capacity in CF-LVAD Patients.

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 24, 2016

Conditions
Heart Failure
Trial Locations (1)

2100

University Hospital Rigshospitalet., Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT02303236 - Biological Markers Predicting Exercise Capacity in CF-LVAD Patients. | Biotech Hunter | Biotech Hunter